• Wrong document? Swap it for free
  • Written by students who passed
  • Immediately available after payment
  • Read online or as PDF
Sell
Where do you study
Your language
Document preview thumbnail
Preview 2 out of 12 pages
Summary

Summary Nr 546 assignment antipsychotics table

Document preview thumbnail
Preview 2 out of 12 pages

Drug name Indication Target symptoms: state if positive or negative effect Potency (if noted. receptor occupancy if noted ) Neurotransmitter(s) affected Half-life (T1/2), metabolism (CYP 450 enzyme) Notable side effects (associate to pathway or NT) Typical antipsychotics (conventional) Haloperidol Blocks dopamine 2 receptors, reducing positive symptoms of psychosis and possibly combative, explosive, and hyperactive behaviors Blocks dopamine 2 receptors in the nigrostriatal pathway, improving tics and other symptoms in Tourette’s syndrome. Decanoate half-life approximately 3 weeks Oral half-life approximately 12–38 hours Acute blockade of dopamine 2 receptors in the striatum can cause drug-induced parkinsonism, dystonia, or akathisia Chronic blockade of dopamine 2 receptors in the striatum can cause tardive dyskinesia By blocking dopamine 2 receptors in the pituitary, it can cause elevations in prolactin By blocking dopamine 2 receptors excessively in the mesocortical and mesolimbic dopamine pathways, especially at high doses, it can cause worsening of negative and cognitive symptoms (neuroleptic-induced deficit syndrome). Blocking alpha 1 adrenergic receptors can cause dizziness, hypotension, and syncope Thioridazine Blocks dopamine 2 receptors, reducing positive symptoms of psychosis Metabolized by CYP450 2D6 Acute blockade of dopamine 2 receptors in the striatum can cause drug-induced parkinsonism, dystonia, or akathisia. Chronic blockade of dopamine 2 receptors in the striatum can cause tardive dyskinesia By blocking dopamine 2 receptors in the pituitary, it can cause elevations in prolactin By blocking dopamine 2 receptors excessively in the mesocortical and mesolimbic dopamine pathways, especially at high doses, it can cause worsening of negative and cognitive symptoms (neuroleptic-induced deficit syndrome) Blocking muscarinic cholinergic receptors can cause dry mouth, blurred vision, urinary retention, constipation, and paralytic ileus Antihistaminic actions may cause sedation, weight gain Blocking alpha 1 adrenergic receptors can cause dizziness, hypotension, and sy...

Content preview

Drug name Indication Half-life (T1/2), Notable side effects (associate to pathway or NT)
Target symptoms: state if positive or negative effect metabolism
Potency (if noted. receptor occupancy if noted ) (CYP 450
Neurotransmitter(s) affected enzyme)


Typical antipsychotics (conventional)
Haloperidol Blocks dopamine 2 receptors, reducing positive Decanoate Acute blockade of dopamine 2 receptors in the
symptoms of psychosis and possibly combative, half-life striatum can cause drug-induced parkinsonism,
explosive, and hyperactive behaviors Blocks dopamine approximately dystonia, or akathisia
2 receptors in the nigrostriatal pathway, improving tics 3 weeks Oral Chronic blockade of dopamine 2 receptors in the
and other symptoms in Tourette’s syndrome. half-life striatum can cause tardive dyskinesia
approximately By blocking dopamine 2 receptors in the pituitary,
12–38 hours it can cause elevations in prolactin
By blocking dopamine 2 receptors excessively in
the mesocortical and mesolimbic dopamine
pathways, especially at high doses, it can cause
worsening of negative and cognitive symptoms
(neuroleptic-induced deficit syndrome).
Blocking alpha 1 adrenergic receptors can cause
dizziness, hypotension, and syncope
Thioridazine Blocks dopamine 2 receptors, reducing positive Metabolized Acute blockade of dopamine 2 receptors in the
symptoms of psychosis by CYP450 2D6 striatum can cause drug-induced parkinsonism,
dystonia, or akathisia.
Chronic blockade of dopamine 2 receptors in the
striatum can cause tardive dyskinesia
By blocking dopamine 2 receptors in the pituitary,
it can cause elevations in prolactin
By blocking dopamine 2 receptors excessively in
the mesocortical and mesolimbic dopamine
pathways, especially at high doses, it can cause
worsening of negative and cognitive symptoms
(neuroleptic-induced deficit syndrome)
Blocking muscarinic cholinergic receptors can

, cause dry mouth, blurred vision, urinary retention,
constipation, and paralytic ileus
Antihistaminic actions may cause sedation, weight
gain Blocking alpha 1 adrenergic receptors can
cause dizziness, hypotension, and syncope
Thiothixene Blocks dopamine 2 receptors, reducing positive Initial Acute blockade of dopamine 2 receptors in the
symptoms of psychosis elimination striatum can cause drug-induced parkinsonism,
Commonly prescribed for schizophrenia and bipolar half-life dystonia, or akathisia
disorder approximately Chronic blockade of dopamine 2 receptors in the
3.4 hours striatum can cause tardive dyskinesia.
Terminal By blocking dopamine 2 receptors in the pituitary,
elimination it can cause elevations in prolactin
half-life By blocking dopamine 2 receptors excessively in
approximately the mesocortical and mesolimbic dopamine
34 hours pathways, especially at high doses, it can cause
worsening of negative and cognitive symptoms
(neuroleptic-induced deficit syndrome)
Blocking muscarinic cholinergic receptors can
cause dry mouth, blurred vision, urinary retention,
constipation, and paralytic ileus
Antihistaminic actions may cause sedation, weight
gain Blocking alpha 1 adrenergic receptors can
cause dizziness, hypotension, and syncope.
Fluphenazine Blocks dopamine 2 receptors, reducing positive Mean half-life Acute blockade of dopamine 2 receptors in the
symptoms of psychosis of oral striatum can cause drug-induced parkinsonism,
Commonly prescribed for Bipolar disorder formulation dystonia, or akathisia
approximately Chronic blockade of dopamine 2 receptors in the
15 hours Mean striatum can cause tardive dyskinesia
half-life of By blocking dopamine 2 receptors in the pituitary,
intramuscular it can cause elevations in prolactin.
formulation By blocking dopamine 2 receptors excessively in
approximately the mesocortical and mesolimbic dopamine
6.8–9.6 days pathways, especially at high doses, it can cause
worsening of negative and cognitive symptoms

Document information

Uploaded on
July 3, 2023
Number of pages
12
Written in
2022/2023
Type
Summary
$9.49

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
LearnWithLeo
4.8
(225)
Sold
2632
Followers
13
Items
6514
Last sold
1 week ago



Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions